References
- Aihara M, Truong L D, Dunn J K, et al. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol 1994; 25: 797–801
- Epstein J I. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 1995; 26: 223–229
- Baisden B L, Kahane H, Epstein J I. Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy. Am J Surg Pathol 1999; 23: 918–924
- Aydin H, Zhou M, Herawi M, et al. Number and location of nucleoli and presence of apoptotic bodies in diagnostically challenging cases of prostate adenocarcinoma on needle biopsy. Hum Pathol 2005; 36: 1172–1177
- Colombel M, Vacherot F, Diez S G, et al. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. Br J Urol 1998; 82: 380–385
- Henneberry J M, Kahane H, Humphrey P A, et al. The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy. Am J Surg Pathol 1997; 21: 725–728
- Holmes E J. Crystalloids of prostatic carcinoma: relationship to Bence-Jones crystals. Cancer 1977; 39: 2073–2080
- Ro J Y, Ayala A G, Ordonez N G, et al. Intraluminal crystalloids in prostatic adenocarcinoma. Immunohistochemical, electron microscopic, and x-ray microanalytic studies. Cancer 1986; 57: 2397–23407
- Helpap B. Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease. Histopathology 1988; 13: 203–211
- Kyprianou N, Tu H, Jacobs S C. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 1996; 27: 668–675
- Montironi R, Magi Galluzzi C, Scarpelli M, et al. Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia. Virchows Arch A Pathol Anat Histopathol 1993; 423: 351–357
- Vesalainen S, Lipponen P, Talja M, et al. Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate 1995; 26: 80–86
- Kronz J D, Milord R, Wilentz R, et al. Lesions missed on prostate biopsies in cases sent in for consultation. Prostate 2003; 54: 310–314
- Varma M, Lee M W, Tamboli P, et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med 2002; 126: 554–561
- Cina S J, Epstein J I. Adenocarcinoma of the prostate with atrophic features. Am J Surg Pathol 1997; 21: 289–295
- Egan A J, Lopez-Beltran A, Bostwick D G. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process. Am J Surg Pathol 1997; 21: 931–935
- Humphrey P A, Kaleem Z, Swanson P E, et al. Pseudo-hyperplastic prostatic adenocarcinoma. Am J Surg Pathol 1998; 22: 1239–1246
- Levi A W, Epstein J I. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. Am J Surg Pathol 2000; 24: 1039–1046
- Nelson R S, Epstein J I. Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. Am J Surg Pathol 1996; 20: 419–426
- Murphy W M, Ramsey J, Soloway M S. A better nuclear fixative for diagnostic bladder and prostate biopsies. J Urol Pathol 1993; 1: 79–87